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CHAPTER 1 
INTRODUCTION:  
               Dr. Archie Brain’s ‘Laryngeal Mask Airway’, a supraglottic device 
introduced in 1981[1] made a revolution in the management of airway, replacing 
the most commonly used endotracheal tubes for general anaesthesia by negating 
the need for laryngoscopy and sometimes muscle relaxants. Since then many 
other Supraglottic airway devices have been developed and added to the 
supraglottic airway device family.  
    Supraglottic airway devices (SAD) are an alternate to facemasks and 
endotracheal tubes and are designed to provide ventilation, oxygenation and 
administration of anaesthetic gases to a patient admitted for a surgical procedure 
under general anaesthesia or during a respiratory arrest. Previously, SADs were 
mainly used for maintenance of a patent airway during elective procedures under 
general anaesthesia but, during years following the introduction of the 
prototypical classic LMA, these devices have also found other areas of utilization, 
like as conduits for tracheal intubation in difficult airway [2] or as airway adjuncts 
in cardiac arrest in prehospital setting[3]. Compared to endotracheal intubation, 
the use of SAD’s is associated with stable haemodynamics [4], intracranial 
pressure[5] and intraocular pressure[6-8]. A potential risk of SAD use is incomplete 
airway sealing, which may cause gastric insufflation at pressures above 20cmH2O 
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by opening the oesophageal sphincter. The newer SAD’s are designed to decrease 
the risk of aspiration and to increase the oropharyngeal leak pressure (OLP), 
improving the airway seal at higher airway pressures during intermittent positive 
pressure ventilation without significant gastric inflation. 
              Proseal LMA is a second generation reusable supraglottic airway device 
with an airway lumen and a drain tube. The drain tube helps in decompression of 
stomach and drainage of regurgitant material. The median airway seal with a 
Proseal LMA is above 30cm H2O
[9]. The PLMA was designed so that the larger, 
wedge‐shaped cuff would plug gaps in the proximal pharynx and the flat dorsal 
cuff would push the ventral cuff more firmly into the peri-glottic tissues. There is 
evidence towards the cuff of Proseal LMA exerting higher pressure on the 
laryngopharyngeal mucosa causing nerve injury, impeding venous and lymphatic 
return.  
               BASKA MASK is the latest addition to the supraglottic airway devices, 
with a cuffless dynamic self inflating membranous bowl and a dual drainage tube 
system for effective drainage of gastric contents providing option for continuous 
suctioning of gastric contents. As there is no inflated cuff in the Baska mask, 
neither does it cause tissue or nerve damage nor does it require intracuff pressure 
monitoring.  The newer Baska mask has many novel features which improves 
safety when used during controlled ventilation or in spontaneously breathing 
patients[10-11].  
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               Ease of insertion, airway sealing pressure, ability to protect against 
gastric regurgitation, ease of intubation through the device, patient comfort and 
cost need to be considered while choosing a Supraglottic airway device. 
             To the best of our knowledge, there is only one study comparing Proseal 
LMA with Baska mask, hence we conducted this study to generate more evidence 
on the safety and efficacy of the newer Baska mask compared to Proseal LMA. 
In this study conducted in the Department of Anaesthesiology and Critical care, 
Government Stanley Medical College and Hospital, we have compared the 
Proseal LMA with its proven efficacy in reducing aspiration and withstanding 
higher sealing pressure with the newer Baska mask in terms of Airway sealing 
pressure, ease of insertion, perioperative complications and postoperative 
laryngopharyngeal morbidity.  
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Chapter 2 
AIM OF THE STUDY 
To compare the sealing pressure of the Bask mask with Proseal laryngeal 
mask in adult patients undergoing elective surgeries under general anaesthesia 
with intermittent positive pressure ventilation.  
 
PRIMARY OBJECTIVES  
To determine the Airway sealing pressure at 5mins, 30mins post placement 
and at the end of surgery.   
 
SECONDARY OBJECTIVES  
             To determine the Insertion time, number of attempts, ease of insertion, 
Post-operative laryngopharyngeal morbidity of the supraglottic airway device in 
the study population.  
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Chapter 3 
INTRODUCTION TO SUPRAGLOTTIC AIRWAY DEVICES 
Airway management devices that are placed above the glottis and allow 
gases to enter and exit the airway are referred to as “Supraglottic airway devices”. 
They provide a bridge between facemask and tracheal tube in terms of anatomical 
position and degree of invasiveness[12]. Most supraglottic airway devices (SADs) 
are designed for use during routine anaesthesia, but there are other roles such as 
airway rescue after failed tracheal intubation, use as a conduit to facilitate tracheal 
intubation and use by primary responders at cardiac arrest or other out-of-hospital 
emergencies. Supraglottic airway devices (SAD) play an important role in the 
management of patients with difficult airways. Therefore, the use of the LMA is 
now included in many difficult airway guidelines. The American Society of 
Anaesthesiologists includes the LMA as a ventilatory device at two points in the 
algorithm: first in the anaesthetised patient whose trachea cannot be intubated 
(anaesthetised non-emergency limb); and second in the anaesthetised patient 
whose trachea cannot be intubated and whose lungs cannot be conventionally 
ventilated (anaesthetised emergency limb).  
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HISTORY OF SUPRAGLOTTIC DEVICES:  
In the early 20th century, endotracheal intubation was a very complex 
procedure, with a high failure rate[13]. Awake intubation was quite difficult due to 
gag reflex and laryngospasm was very common, often resulting in mortality.   
 Trying to find a solution for these problems, Leech introduced the 
Pharyngeal Bulb Gasway in 1937[14]. Instead of entering into the trachea, this 
device would be stuck in the pharynx by means of an anatomically-shaped, 
hollow rubber bulb, becoming the first supraglottic airway device (SAD). Despite 
the advantages of Leech's airway compared to the face mask (FM) or the ET at 
the time, it was never very popular.  
The use of curare as muscle relaxant by Griffith and the refinement of 
the laryngoscope by Macintosh led to the widespread adoption of tracheal 
intubation as the gold standard for airway management in general anaesthesia.  
In 1981, Archie Brain designed the first laryngeal mask airway, which was 
called LMA classic, at the Royal London Hospital. The classic LMA was first 
sold in the United Kingdom in 1988, and then the United States in 1992 by LMA 
North America[1]. 
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Fig 1: Classic LMA  
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CHAPTER 4 
ADVANTAGES AND DISADVANTAGES OF SAD[12] 
ADVANTAGES: 
➢ Ease of insertion 
➢ Smooth emergence 
➢ It is tolerated at lighter planes of anesthesia with a lower risk of 
bronchospasm, laryngospasm and sore throat. 
➢ Avoiding the complications of intubation and face mask 
➢ ADVANTAGES OVER THE ENDOTRACHEAL TUBE: 
1. The ease of insertion is greater and has a faster learning curve. 
2. Laryngoscopy and muscle relaxants are not always needed. 
3. Haemodynamic changes are less when compared with the endotracheal 
tube. 
4. Time for insertion is less. 
5. Incidence of sore throat is less. 
6. Less manipulations of airway compared with endotracheal tube in a 
reactive airway. 
• ADVANTAGES OVER FACEMASK: 
1.Hands free technique. 
2. Work of breathing (WOB) is less with the LMA. 
3.  Airtight seal with an LMA. 
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4. Better airway protection against regurgitation when compared with the 
facemask. 
5. Children with a difficult mask fit do well with an LMA. Oropharyngeal 
airway obstruction is avoided. 
6. Less operating room pollution as waste gases can be scavenged. 
 
DISADVANTAGES: 
• Relative contraindications to use of the LMA include situations 
associated with increased risk of aspiration (full stomach, previous gastric 
surgery, gastroesophageal reflex, diabetic gastroparesis, >14 weeks 
pregnant, dementia, trauma, opiate medications, increased intestinal 
pressure) unless other techniques for securing the airway have failed. 
• Patient with glottic and supraglottic obstruction. Supraglottic 
pathologies make the proper positioning of SAD difficult. 
• Requirement of paralysis or obtunded airway reflexes: It can’t be 
inserted unless the jaw and pharynx are fully relaxed. 
• Less reliable airway:  Does not secure a definitive airway.  
• Unreliable drug administration: Drug administration through LMA 
during resuscitation is not as reliable as a tracheal tube. 
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CHAPTER 5 
USES OF SUPRAGLOTTIC AIRWAY DEVICES[12]: 
➢ Difficult face mask technique: In difficult airway scenarios like 
Edentulous patients, facial injuries, facial contour not suiting face masks, 
facial burns without upper airway burns. 
➢ Difficult or failed intubations: In cannot intubate situations or in can’t 
intubate can’t ventilate situations, supraglottic airway device may be 
lifesaving by maintaining adequate ventilation or to facilitate passage of 
tracheal tube. In anticipated difficult airway like Pierre Robin or Treacher 
Collin syndrome, poor neck mobility, pressure of cervical collar, 
supraglottic airway device can be used as primary airway device and to 
facilitate intubation. 
➢ Resuscitation: Classic LMA and Fastrach LMA have been successfully 
used for cardiac arrest in adults and in neonates. It is also used in out of 
hospital situations like air transit.  
➢ Ophthalmic surgery: Intraocular pressure is lower after inserting a LMA 
than a tracheal tube and also during emergence. 
➢ Tracheal procedure: Compression of the trachea by a mediastinal mass 
can cause problems similar to tracheal stenosis. Mediastinoscopy and 
thoracotomy have been performed with LMA and spontaneous ventilation.  
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➢ Supraglottic devices can be used for procedures like Tracheal tube 
exchange, Transesophageal echocardiography and  Endoscopic 
procedures[12].  
➢ Paediatric patients: Supraglottic airway devices (SADs) have been used 
increasingly in pediatric anesthesia. It is used as an alternative to tracheal 
tube in children with URI. The ProSeal laryngeal mask airway (PLMA) 
has been considered a reliable SAD in children with its superior ability for 
airway sealing even under high pressure. It is used in situations like 
Subglottic stenosis, anaesthesia for radiotherapy, MRI examinations and in  
those requiring multiple anaesthesia over a short time. SAD  has also been 
used in anticipated difficult airway like Treacher Collins syndrome, Pierre 
Robin syndrome, Beckweith Weidmann syndrome, Goldenhar syndrome  
and Mucopolysaccaridosis. Even though SAD is widely used, larger 
epiglottis makes airway obstruction with SAD more likely in children. 
➢ Supplementary regional block: When surgery outlasts regional block or 
when only a partial block is present, supplementation with general 
anaesthesia using SAD is desirable as it requires lighter plane than tracheal 
tube. 
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CHAPTER 6 
CLASSIFICATION OF SUPRAGLOTTIC AIRWAY DEVICES:  
 Brimacombe, was the first to propose the classification in 2004[15], based 
on three criteria: whether the device has a cuff; if it is introduced through nose or 
mouth; and the anatomic location of the tip when correctly placed. Shortcoming 
of this classification is that most of the devices used belong to the same group in 
this classification - cuffed, introduced through the mouth with the tip at the 
proximal end of the oesophagus. 
 Miller classified SAD based on the sealing mechanism[16], placing all 
SADs in 3 groups: cuffed perilaryngeal sealers; cuffed pharyngeal sealers; and 
pre-shaped cuffless devices. Each of these groups had subgroups and then each 
device could be further categorized as reusable or single-use.  
Hernandez classified SAD[17] based on the presence or absence of a cuff 
and the number of cuffs as a means to develop a nomenclature. He divided all 
SADs into four groups, those with a single periglottic cuff, those with a single 
pharyngeal cuff, those with two cuffs regardless of their location of sealing, and 
those with no cuff.  
In 2011, Cook proposed a new classification[18], dividing all SADs into 1st 
or 2nd generation devices. A first generation SAD has just a simple airway tube, 
with no specific design features for aspiration safety. Second generation SAD 
have a gastric drain tube, improved pharyngeal seal and a bite block.  
 
 
27 
 
Miller felt Cook’s classification to be simple and proposed in 2014[19] 
another classification, based on the sealing mechanism (three generations) and on 
the anatomic location of sealing (base-of-tongue or peri-laryngeal)  
 
Fig 2: Miller’s classification of SAD  
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Fig 3: Cook’s classification of SAD  
 
 
Table 1: Miller's new classification of supraglottic airway devices[19] 
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Table 2: Commonly available SAD features[20]  
 
 
 
Fig 4: DIFFERENT SAD (I)  
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(I) Supralottic devices with airway tube only: (A) intubating laryngeal 
mask airway (B) LMA Unique, (C) classic LMA and (D) disposable 
laryngeal mask  
(II)  Supraglottic devices with both airway and drain tube: (E) Baska 
mask, (F) Ambu AuraGain , (G) LMA Supreme, (H) i-gel  (I) ProSeal 
laryngeal mask airway.  
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Fig 5: DIFFERENT SAD (II) A. COMBITUBE, B. KING LT, C. COBRA 
PERILARYNGEAL AIRWAY , D.SLIPA 
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Oropharyngeal leak pressure:  
OLP is also referred to as airway sealing pressure or airway leak 
pressure[21]. OLP is the anaesthesia circuit pressure at which there is leak around 
the airway. OLP indicates airway protection, successful SGA placement and 
PPV[22,23].  Higher the oropharyngeal leak pressure, greater is the seal between the 
artificial airway and patients’s airway.  Oropharyngeal leak pressure (OLP) is 
measured by closing the expiratory valve of the anesthetic circle system at a fixed 
gas flow rate and noting the equilibrium airway pressure. It is used to quantify 
the efficacy of airway sealing in SAD devices[22]. Several methods are used to 
quantify OLP, including audible noise detection, oral capnography, stethoscopic 
noise and manometric stability. Factors that may affect OLP include the use of 
neuromuscular blockers, intra-abdominal pressure during surgery and intracuff 
pressure of the SAD device[24,25,26] .  
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CHARACTERISTICS OF AN IDEAL SUPRAGLOTTIC DEVICE: 
  
In 2004, Don Miller suggested that the “Core” Desirable Features of a 
Supraglottic Airway were[27]:  
 
• Non-invasive (supraglottic) airway conduit.  
• Easy insertion, even by a nonspecialist. 
 • Good first-time insertion success rate.  
• Stable airway once positioned, i.e. reliable hands-free airway.  
• Sufficient sealing quality to apply PPV.  
• Minimal risk of aspiration.  
• Minimal risk of cross-infection.  
• Minimal risk of serious side-effects. 
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                                               CHAPTER 7 
 
PROSEAL LMA:  
The proseal laryngeal mask airway (PLMA) was introduced by Archie 
Brain in 2000. Proseal LMA is a reusable second generation LMA which is a 
modification of classic LMA with a gastric drain tube to improve controlled 
ventilation, airway protection and diagnosis of misplacement[28,29,30,31].  
 
PARTS OF A PROSEAL LMA:  
It has a larger and deeper bowl with no grills, wire reinforced shorter 
airway tube, second tube placed lateral to airway tube ending at the tip of the 
mask, a dorsal cuff which improves the airway seal, integral bite block, an 
anterior pocket for seating an introducer or finger during insertion. Gastric drain 
tube separates airway from alimentary track channelling the regurgitated gastric 
fluid, providing opportunity to pass Ryle’s tube through the gastric drain tube, 
avoidance of gastric insufflation during positive pressure ventilation. Effective 
mask seal achieved partly by deeper bowl and partly by smaller posterior cuff[12].  
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Fig 6: Proseal LMA 
                                
Table 3: Proseal LMA sizes
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INSERTION TECHNIQUES OF PROSEAL LMA[12]:  
i. Standard technique: 
 The patient’s head is placed in sniffing position (head extended and neck 
flexed). This position is maintained during insertion by the non-inserting 
hand to stabilize the occiput. The Proseal LMA is held like a pen with the 
index finger placed at the junction of the cuff and the two tubes. The tip of 
the cuff is placed against the inner surface of the upper incisor with the 
aperture facing forwards. The mask is pressed against the hard palate by 
using the index finger. A change in direction can be sensed as the mask tip 
encounters the posterior pharyngeal wall, now the index finger is gradually 
withdrawn and the tube is grasped with other hand and then pressed down 
with a single swift movement till a definite resistance is felt.   
ii. Introducer technique:  
A metal introducer is attached to the concave side of the device. As the 
Proseal LMA is inserted the introducer is kept close to the chin, it is swung 
inwards in a smooth circular manner and it is advanced until a resistance is 
felt. The non-dominant hand is used to stabilize the airway tube as the 
introducer is removed out of the mouth. 
iii. Bougie-guided technique: 
 A bougie is placed upside down into the oesophagus and the PLMA is 
railroaded into place via the drain tube (suction catheters or orogastric 
tubes are alternatives). 
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Fig 7: Standard insertion technique  
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Fig 8:   Introducer and stylet guided Proseal LMA insertion  
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ASSESSMENT OF PROPER PLACEMENT:  
                          Once inserted assessment of proper placement is confirmed by 
delivering adequate tidal volume with reasonable peak inspiratory pressure, leak 
pressure  above 20cm of H2O with controlled ventilation and greater than 10 cm 
of H2O with spontaneous ventilation, gel displacement test, easy passage of 
orogastric tube, a normal square capnography and by fibreoptic confirmation. X-
ray or MRI can also be used to confirm the position[32]. 
 
Causes of airway obstruction: 
➢ Incorrect mask position 
➢ Downfolded epiglottis  
➢ Closed glottic sphincter 
➢ Over inflated cuff 
 
Difficulties encountered with Proseal LMA: 
✓ Less suitable as an intubating device because of narrow airway tube. 
✓ It takes comparatively longer time to insert than classic LMA in adults. 
✓ Requires greater depth of anaesthesia for insertion  
✓ Malposition’s are more common with Proseal LMA 
✓ Has a shorter life span than classic LMA. 
 
 
 
 
40 
 
CHAPTER 8 
Baska mask :  
The Baska Mask, an Australian designed and manufactured device which 
is available in four sizes: #3, 4, 5 and 6 for patients ranging between 30 to >100 
kg is made entirely from medical grade silicone, except for the 15 mm connector 
that fits into the proximal ends of the main (ventilation/breathing) airway tube 
and clearance tubes with an interchangeable (left or right) swivel suction elbow, 
attached to either of the suction ports[33, 34]. It is available in both disposable single 
use and reusable forms.   
 It has a cuff-less membranous bowl which inflates and deflates with each 
positive pressure inspiration and expiration respectively, an inbuilt “tab” that 
permits to increase its angulation for easy negotiation of the oropharyngeal curve 
during placement, a dual drainage system for pharyngeal contents; and a bite 
block. The membranous cuff of the Baska Mask appears bulkier than the 
equivalent inflatable cuff on cuffed laryngeal masks. The mask can easily be 
decreased in size during insertion by compressing the proximal, firmer (though 
still easily compressible) part of the mask below the airway tube, between the 
thumb and two fingers.  
It is checked by occluding the airway opening of the proximal connector 
end with one thumb, placing the other thumb over the airway opening of the mask 
to seal and applying pressure for 5 s using a reservoir-bag squeeze to confirm the 
absence of leak in the device. 
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Insertion Technique: The entire body of the mask was lubricated with a water-
based lignocaine gel. The entire mask needs to be lubricated before insertion into 
the mouth, otherwise the bulk of the mask "cuff" may produce resistance as it 
traverses the hypopharynx. With the head in neutral position, Baska mask is 
pushed past the front teeth towards the hard palate, avoiding the tongue. If 
necessary, when the mask is fully within the mouth, the tab, a unique feature of 
the Baska Mask, is used to help negotiate the palato-pharyngeal curve and 
advanced until a definite resistance is felt[34]. 
 
Fig 9: Disposable Silicone Baska mask  
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Fig 10: Special features of BASKA mask 
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Fig 11: Size 3 Baska Mask Insertion      Fig 12: Size 4 Baska Mask Insertion 
 
Fig 13: MONITORS 
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Table 4: Special Characteristics Of Baska Mask[34] 
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CHAPTER 9: 
REVIEW OF LITERATURE 
1. BOSLEY NJ et al[35] studied 98 patients belonging to ASA-PS-I – III 
undergoing elective surgical procedures, randomised to have either the 
LMA Proseal or Igel for spontaneous and controlled ventilation during 
routine anaesthesia. Aim of the study was to determine if there was a 
clinically significant difference in the performance characteristics of two 
second generation SAD. The primary outcome was first attempt insertion 
success and  time of insertion. Secondary outcomes were ease of insertion, 
manipulations to establish patent airway, fiber optic view of larynx, 
complications during anaesthesia, emergence, recovery and anaesthetic 
assess of device performance. They  found that the first time insertion rate 
was higher in LMA proseal group, number of insertion attempts did not 
differ between two groups. Ease of insertion, time to establish a patent 
airway, number of manipulations and anatomical positioning of the device 
and ventilated performance ,total number of complications were similar 
between the two groups. The leak pressure was significantly higher in the 
LMA Proseal group (28cmH2O) than I-Gel (22cmH2O). It was concluded 
that LMA Proseal and I-gel have comparable performance characteristics 
during routine general anaesthesia in non-paralysed patients. The LMA 
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proseal has a higher airway seal  that is statistically significant and clinically 
important. 
 
2. ZUNDERT TV, GATT S. et al[34] evaluated the performance of BASKA 
mask in 50 adult patients belonging to ASA-PS-I-III undergoing surgery 
under general anaesthesia. Patients were induced using Inj. Fentanyl 
1mcg/kg, Inj. Propofol 2.5 mg/kg. Anaesthesia was maintained with 
sevoflurane 1.5%-2% in oxygen 40% in air. The first attempt success rate 
was 88% and overall insertion success rate was considered “easy “ to “very 
easy” in 92% cases. At fiber optic evaluation of anatomical position , vocal 
cord could not be seen in 12% of patients. An oropharyngeal leak pressure 
of >30 cm H 2 O was obtained with all Baska masks, whereas three quarters 
of the patients (76%) had a maximum leak pressure of 40 cm H2O, 
confirming a good airway seal, which is typical for the second-generation 
SAD (e.g. LMA-ProSeal, LMA-Supreme, I-gel)  and much higher than the 
first-generation LMA-Classic-type laryngeal masks. Fiberoptic evaluation 
of the anatomic position of the Baska Mask in situ [revealed that, in half of 
the patients studied (54%), a perfect or near-perfect position of the vocal 
cords could be obtained.  
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3. ALEXIEV, V et al[36] conducted an observational study of BASKA mask 
on 30 female patients of ASA-PS-I-III aged 18yrs or older undergoing non-
urgent surgery lasting for less than 2 hours, it was concluded that the overall 
success rate for device insertion was 96.7%, first insertion success rate was 
76.7%. The mean airway leak pressure was 35.7 cm of water. The incidence 
of throat pain, dysphagia, dysphonia was low. 
 
4. AL-RAWAHI SAS et al[37], studied 52 ASA PS I and II, non-obese 
(BMI<30) adult patients ranging from18-45 yrs of age, belonging to either 
sex undergoing a variety of elective surgical procedures in the supine 
position with SAD placement of ≤ 2 hours duration for a three month 
period. Patients were then randomized into two groups; PLM Group (n=22) 
and BM Group (n=30) according to the use of SAD.  Patients. All patients 
were premedicated with oral 0.1 mg/kg midazolam about an hour prior to 
induction of anesthesia. Anesthesia was induced in the supine position with 
the patient’s head in neutral position using propofol 2–2.5 mg/kg, fentanyl 
1.0-1.5 µg/kg, and cisatracurium 0.1 mg/kg. Anesthesia was maintained 
with sevoflurane 1.0% to 2.0% in a mixture of 60% nitrous oxide and 
oxygen. PLM or BM # 3, 4 or 5 (according to the manufacturers’ 
recommendations) was digitally placed by an anesthesiologist with at least 
15 BM placements previously. They noted that the number of attempts 
needed to place the device correctly, were similar in both of the groups. It 
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was observed that it took a mean of 16.48 sec to place the BM which is 
identical to that observed by van Zundert and Gatt. They found that BM 
placement time was significantly shorter as compared to PLM. However 
they concluded that the short placement time of the BM by 5 sec as 
compared to PLM may not be of much clinical significance. 
 
5. V TRIVEDI et al[38] studied 60 adult patients of ASA grade-I and II posted 
for routine surgeries under general anaesthesia, divided equally into two 
groups group-I and group-II. In group-I, the airway was secured with a 
PROSEAL LMA (PLMA) while in group-II it was secured with I-GEL. 
Number of attempts of insertion and mean duration of insertion in both 
groups were noted. In group-I the mean duration of insertion was 11.73 
(±3.084) sec while in group-II it was 9.63 (±2.23) sec. Changes in mean 
pulse rate in both groups were comparable, statistically not significant. 
Changes in mean arterial pressure (MAP) was significant intraoperatively, 
higher in Proseal group. It was concluded that I -gel airway is a better 
alternative user friendly device than PLMA in patients with high risk and 
having predicting difficult airway because of ease of insertion and 
maintenance of haemodynamic stability. 
 
6. GAURAV CHAUHAN et al[39], did  a randomized controlled study in 80 
patients [Group I - I-gel insertion (n = 40) and Group P - LMA Proseal 
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insertion (n =40)] of ASA grades I/II, of either sex in the age group 18-65 
years. Both groups were compared with respect to ease of insertion, 
insertion attempts, fiberoptic assessment, airway sealing pressure, ease of 
gastric tube placement, and other complications. Mean insertion time for 
the I-gel (11.12 ± 1.814 sec) was significantly lower than that of the PLMA 
(15.13 ± 2.91 sec). I-gel was easier to insert with a better anatomic fit. Mean 
airway sealing pressure in the PLMA group (29.55 ± 3.53 cm H 2 O) was 
significantly higher than in the I-gel group (26.73 ± 2.52 cm H 2 O; P = 
0.001). Ease of gastric tube insertion was significantly higher in the I-gel 
group (P = 0.001). Incidence of blood staining of the device, sore throat and 
dysphagia were observed more in PLMA group. No other complications 
were observed in either of the groups. 
 
7. WOO JAE JEON et al[40],   studied 30 adult patients randomly allocated 
to two groups (the PLMA or I-gel group). Insertion time and number of 
attempts were recorded. Time to insertion was similar (26.4 ± 1.4 and 26.4 
± 0.8 for PLMA and I-gel, respectively).  After successful insertion, airway 
leak pressure was measured. Oropharyngeal leak pressure was determined 
by closing the expiratory valve of the circle system at a fixed gas flow of 3 
L/ min and noting the airway pressure (maximum allowed was 40 cm H2O) 
at which equilibrium was reached. Leak pressure did not vary significantly 
either between or within groups after CO2 insufflation. Leak volume was 
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the difference between the inspired versus the expired tidal volume.  The 
leak fraction was calculated as the leak volume divided by inspired tidal 
volume. In addition, differences between leak volume and leak fraction 
between groups were not significant.  It was concluded that the I-gel was a 
reasonable alternative to the PLMA for controlled ventilation during 
laparoscopic gynaecologic surgery. 
 
8. R. E. GALGON et al[41], conducted a study on 100 subjects (ASA-PS 1–
3) presenting for elective, outpatient surgery, randomly assigned to air-QR 
and  ProSeal devices. The primary study endpoint was airway seal pressure. 
Mean (SD) airway seal pressures for the air-QR and ProSeal were 30 
cmH2O and 30 cmH2O, respectively. Postoperative sore throat was more 
common with the air-QR (46% vs 38%, p = 0.03) as was pain on swallowing 
(30% vs 5%, p = 0.01). It was concluded that, the air-QR performs well as 
a primary airway during the maintenance of general anaesthesia with an 
airway seal pressure similar to that of the ProSeal, but with a higher 
incidence of postoperative oropharyngolaryngeal complaints.  
 
9. SHARMA M et al[42], randomly allocated 120 patients to four groups, 
according to composition of gases used to inflate the PLMA cuff to achieve 
40 cmH2O cuff pressure, air (Group A), 50% O2:air(Group OA), 50% 
O2:N2O (Group ON) and 100% O2 (Group O). After induction of general 
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anaesthesia, Ventimask tubing was attached to fresh gas outlet of Drager 
anaesthesia work station for desired composition of gas for different groups 
(air [Group A], O2:air [50% O2] [Group OA], O2:N2O [50% O2] [Group 
ON] or 100% O2 [Group O]) according to the group. The other end of the 
tubing was attached to 50 ml syringe via three‑way assembly. The fresh gas 
flow was set at desired concentration and gas mixture at 5 L flow. Once 
desired gas is filled in the syringe, three‑way was put in off position towards 
syringe and disconnected from the tubing. After PLMA insertion , cuff was 
inflated by the specified syringe to obtain a cuff pressure of 40 cmH2O with 
the help of aneroid cuff pressure manometer, attached to the pilot balloon. 
Cuff pressure, cuff volume and ventilator parameters were monitored 
intraoperatively. At cuff pressure of 40 cmH2O, oropharyngeal leak 
pressure (OLP) was checked by closing adjustable pressure limiting valve 
at fixed gas flow of 3 L/min. The airway pressure at which leak was heard 
(by stethoscope) was noted. Pharyngolaryngeal parameters were assessed 
at 1, 2 and 24 h postoperatively. There was statistically significant increase 
in the gas volume in the PLMA cuff in the Group A, Group OA and O. 
There was insignificant decrease in the gas volume in Group ON.  The 
incidence of sore throat, dysphagia, and dysphonia were not statistically 
significant at any point of time till 24 h in between the groups. Sore throat 
did not have a statistically significant correlation with cuff pressure . Sore 
throat had statistical significant correlation with duration of anaesthesia , 
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with more than one attempt of LMA insertion , blood on LMA , oral 
suctioning. None of the predictors showed correlation with dysphagia and 
dysphonia. 
 
10. G. SHANMUGAVELU et al[43] ,  studied 60 patients of either sex 
scheduled for short duration laparoscopic  surgeries (<2 hrs). The study 
conducted on ASA I and II patients with a BMI of <30kg/m2. Patients were  
induced with fentanyl 2μg/ kg, propofol 2-2.5mg/kg and neuromuscular 
paralysis facilitated with atracurium 0.5mg/kg. Anaesthesia was maintained 
with oxygen, air (fio2 40%) with isoflurane1.5-2%. Oropharyngeal seal 
pressure was measured after five minutes of placement. FGF 5L/min was 
used after closing the APL valve at 70cm h2o, recording the pressure at 
which pressure is plateaued. Presence of sore throat, dysphagia and 
dysphonia were examined 2hrs and 24hrs post operatively.  The insertion 
time was shorter for I-gel (12.3±3.8secs) than Baska mask (20.1±8.1secs). 
Oropharyngeal leak pressure was significantly higher for Baska mask (24-
32cmh20). Oropharyngeal airway morbidity was not significantly different 
between two groups. 
 
11. ISHWARSINGH et al[44] studied comparison of clinical performance of I-
gel with LMA proseal in elective surgeries. 60 ASA I,II adult patients were 
randomly assigned into 2 groups. Group I(n=30) for I-gel and group 
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P(n=30) for LMA proseal. The success rate of first attempt of insertion and 
ease of gastric tube placement was more with group I. Blood staining of 
device and tongue, lip and dental trauma was more with group P. There was 
no evidence of bronchospasm, laryngospasm, regurgitation, aspiration or 
hoarseness in either group.  
 
12. SUN KYUNG PARK et al[45] Conducted a systematic review and meta 
analysis to identify randomized clinical trials that compared the LMA-
Proseal with the i-gel during general anesthesia. Twelve randomized 
clinical trials met the eligibility criteria. It was found that, there were no 
significant differences in insertion success rate at the first attempt, ease of 
insertion, oropharyngeal leak pressure (OLP), quality of fiberoptic view and 
success rate of gastric tube insertion between the i-gel and the LMA-
Proseal, respectively. The I-gel had a shorter insertion time than the LMA-
Proseal and a lower incidence of blood staining on the device, sore throat 
and dysphagia. It was concluded that both devices were comparable in ease 
of insertion and both had sufficient OLP to provide a reliable airway. The 
i-gel was found to have fewer complications (blood staining, sore throat, 
dysphagia) than the LMA-P and offers certain advantages over the LMA-
Proseal in adults under general anesthesia.  
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13. HYE WON SHIN et al[46] conducted a meta-analysis and systematic 
review on  Comparison of oropharyngeal leak pressure and clinical 
performance of LMA ProSeal and I-gel in adults and concluded that that 
LMA ProSeal provides superior airway sealing (higher OLP) compared to 
I-gel, while I-gel offers rapid insertion time, and lower incidences of blood 
on the device after removal and sore throat compared to LMA ProSeal in 
anesthetized adult patients. 
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                                                     CHAPTER 10: 
MATERIALS AND METHODS 
This was a prospective randomized study done on patients undergoing 
elective surgeries in the Department of Anaesthesiology, Stanley Medical 
College, Chennai. 
 After obtaining the approval of the Institutional Ethical Committee, a 
randomized, prospective study was conducted on 70 patients over a period of six 
months. 
 
SAMPLE SIZE:  
           In a study conducted by Sharifa Ali Sabeeh Al-Rawahi et al[31] the mean 
airway sealing     pressure was 29.98±8.51 in Baska mask group ( n= 30) and 
24.50±6.19 in Pro-seal group (n=22). To detect similar difference in means with 
80% power, a sample size of 70 (35 in each group) was calculated with nMaster 
software Version 2.0 by applying the following formula. 
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Randomization was done by allocating the patients to either the Proseal 
group (PLM) or Baska group (BM) by computer generated random numbers. 
Each group had 35 patients. The patients who met the inclusion and exclusion 
criteria were only included in the study. 
To find the association of significance in categorical data the Chi-Square 
test was used. In all the statistical tools the probability value of 0.05 was 
considered as significant level.  
PRE-ANESTHETIC EVALUATION: 
Pre anesthetic assessment was done by recording a detailed history and 
performing a complete physical examination including airway examination. 
Complete blood count, Renal function tests, Random blood sugar, 
electrocardiograph and chest X ray were done. Patients were explained about the 
procedure in detail and written informed consent was obtained for the same. 
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SELECTION OF CASES:  
 
INCLUSION CRITERIA: 
                           All consented adult patients aged between 18 – 65 yrs belonging 
to ASA physical status I - II undergoing elective surgical procedures requiring 
general anaesthesia with Intermittent positive pressure ventilation of less than 2 
hours duration.  
 
EXCLUSION CRITERIA: 
 Anticipated difficult airway 
 Mouth opening of <2.5 cm 
 Increased risk of aspiration (Pregnancy, BMI > 30, GERD, hiatus hernia) 
 Patients with increased airway resistance and decreased lung compliance 
(obstructive and restrictive lung diseases) 
 Requiring surgery in the non-supine position 
 Patient refusal 
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EQUIPMENTS: 
1. Anaesthesia work station  
2. Oxygen source  
3. Suction apparatus  
4. Intravenous cannula  
5. 10 ml syringe   
6. Sterile gloves 
7. Supraglottic airway device (Baska mask, Proseal LMA )  
8. Water soluble lubricant (lignocaine) gel 
9. Plasters  
 
Fig 14:  Equipments  
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GROUPS    
 GROUP PLM 
General anaesthesia maintained with Proseal LMA.  
 GROUP BM 
General anaesthesia maintained with Baska mask.  
MONITORING    
1.Heart rate 
2.Continuous ECG 
3.Peripheral oxygen saturation 
4.Noninvasive blood pressure 
5.ETCO2  
METHODOLOGY : 
After institutional Ethics Committee approval and informed written 
consent, 70 ASA I-II patients were  selected for the study based on the inclusion 
and exclusion criteria.   Patients were randomised into two groups i.e. group PLM 
& group BM using computerised random number. 
On arrival of the patient in the operating room standard anaesthesia  
monitors like pulse oximeter, non invasive BP and ECG  were  connected and 
baseline values (values taken just before the start of the procedure) of HR, BP, 
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SPO2  were recorded. Peripheral IV access obtained with 18G IV cannula. 
Patients were premedicated with Inj.Glycopyrrolate 0.2mg IV, Inj.Midazolam 
1mg IV. 
 Anesthesia induced using Inj.Fentanyl 2micg/kg, Propofol 2 mg/kg 
and relaxation obtained with Inj.Atracurium 0.5mg/kg IV,with the patient in the 
supine position with the patient’s head in neutral position. 
The supraglottic airway device inserted as per the group allotment and 
anaesthesia was maintained with sevoflurane 1-2% in a 66% nitrous in oxygen 
mixture. 
 
GROUP BM:  
✓  Baska mask Size three (30 to 50 kg), size four (50 to 70 kg) selected as 
per manufacturers recommendations.  
✓ The integrity and function of the Baska Mask checked.  
✓ With patients head in neutral position, the Baska mask is pushed past the 
front teeth towards the hard palate, avoiding the tongue. If necessary, when 
the mask is fully within the mouth, the tab, a unique feature of the Baska 
Mask, is used to help negotiate the palato-pharyngeal curve. 
✓ Correct placement of device confirmed by observing the amplitude of end‐
tidal carbon dioxide waveforms (square waveform pattern) and the 
presence of bilateral chest movements and SpO2 of >95%. 
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GROUP PLM:  
✓ Manufacturers guidelines followed for sizing (size 3 for 30-50kg, size 4 for 
50-70kg) 
✓   Patients head placed in sniffing position and a firm pillow placed under 
the patients occiput.  
✓ Standard Insertion (digital method) technique followed for PLMA 
insertion.  
✓ Cuff inflated with 20ml of air for size 3 LMA and 30ml of air for size 4 
LMA.  
✓ Correct placement was confirmed similar to group BM. 
 
If device placement fails, manipulations including jaw thrust, chin lift, head 
extension or flexion, in/out movements done. Maximum of 2 reattempts done for 
failed placement which was later switched over to endotracheal intubation. 
Haemodynamic monitoring was done and any untoward haemodynamic changes 
were noted.  
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Definitions of parameters measured:  
1. AIRWAY SEALING PRESSURE OR OROPHARYNGEAL LEAK 
PRESSURE:  APL valve closed to 40cm of H2O and a constant fresh gas 
flow of 6L/min is kept and continuous pressure applied over reservoir bag. 
The pressure at which there is no further increase in airway pressure is taken 
as the oropharyngeal leak pressure.  Airway pressure was not allowed to 
rise above 40 cmH2O.   
2. INSERTION TIME: Time from taking SAD in hand to obtaining first 
rectangular capnogram.  
3. ATTEMPT: SAD removed and reinserted.  
4. LPM (LARYNGOPHARYNGEAL MORBIDITY) score = sum of sore 
throat, dysphagia and hoarseness 
Scores 0 1 2 3 
Sore throat none minimal moderate Severe; never an SAD 
again 
Dysphagia none minimal moderate Severe; cannot eat 
Hoarseness none minimal moderate Severe; cannot speak 
   Table 5:  LPM SCORE 
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5. EASE OF INSERTION GRADING:  
• Easy: single pass without manipulations or significant resistance 
• Slight difficulty: single pass with upto 2 manipulations or 1 
complication 
• Difficult : ≥ 2 attempts or >2 manipulations or > 1 complication  
• Impossible: Three failures 
Manipulations: jaw thrust, chin lift, head extension or flexion, in/out 
movements. 
Complications during insertion: Soft tissue damage, dental damage, bleeding, 
hypoxia SpO2<92%, failure to establish/maintain airway, regurgitation, 
aspiration, laryngospasm, gagging, coughing, stridor, gross movement, others. 
 
6. INTRAOPERATIVE COMPLICATIONS: 
• Dislodgement 
• Regurgitation 
• Hypoxia 
• Laryngospasm 
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7.  COMPLICATIONS DURING EMERGENCE:  
• Regurgitation 
• Dislodgement 
• Laryngospasm 
• Hypoxia 
• Vomiting 
• Nausea 
• Staining of supraglottic device with blood/secretions 
• Others 
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CHAPTER 11 
OBSERVATIONS AND RESULTS: 
Findings:  
A Prospective randomized control study for six months of seventy patients 
using Baska mask (n=35, 50%) and Proseal Laryngeal Mask (n=35, 50%) 
revealed the following results. 
 
Age distribution:  
  The following table shows the mean age distribution between the two study 
groups. Analysis of age distribution between both the groups showed the mean 
age of 33.09 (S.D=12.862) in BM group and 37.37 (S.D=14.25) in PLM group.  
 
AGE 
 BM PLM 
Mean 33.09 37.37 
S.D 12.862 14.25 
p-value >0.05 
 
Table 6: Mean age distribution  
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The following figure shows the mean age distribution between two groups.  
 
 
 
Figure 15: Mean Age distribution  
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BMI distribution 
 The following table shows the mean BMI distribution between the two 
study groups. Analysis of BMI distribution between both the groups showed the 
mean BMI of 22.14 (S.D=3.083) in BM group and 22.73 (S.D=2.94) in PLM 
group.  
BMI 
 BM PLM 
Mean 22.14 22.73 
S.D 3.083 2.94 
p-value >0.05 
 
 Table 7: Mean BMI Distribution 
 
 
 
 
Figure 16: Mean BMI distribution  
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Gender distribution between the two groups 
The following figure shows the gender distribution between two groups. 
There were more number of females in our study. There were 24 (68.6%) females 
in BM groups while there were 21(60%) females in PLM group.  
 
 
Figure 17: Gender distribution between two groups 
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Modified Mallampatti Score between two groups 
 
              
              Modified Mallampatti Score between both the groups is seen in the 
following table. Majority of them had MPC II (BM=51.4%; PLM=60%). The chi-
square test for Modified Mallampatti score between both the groups shows a 
value of 1.764 which is not statistically significant.  
 
 
 GROUP Total Pearson 
Chi-
Square 
p-
value 
BM PLM   
MPC I 17 (48.6%) 13 (37.1%) 30 1.764a >0.05 
II 18 (51.4%) 21 (60%) 39  
III 0 1 (2.9%) 1   
Total 35 35 70  
 
Table 8: Modified Mallampatti Score between two groups 
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Following figure shows the MPC distribution between both the groups.  
 
 
 
Figure 18: Modified Mallampatti score between two groups 
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ASA-PS between two groups 
 
Table 9 shows the distribution of number of patients according to ASA-PS 
classification. Majority of them were in ASA PS I (BM=65.7%; PLM=60%). Chi-
square test shows a value of 0.245 which is not statistically significant (p>0.05).  
 GROUP Total Pearson 
Chi-
Square 
p-
value 
BM PLM   
ASA-PS I 23 (65.7%) 21 (60%) 44 0.245 >0.05 
II 12 (34.3%) 14 (40%) 26   
Total 35 35 70   
 
Table 9: ASA-PS between two groups 
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The following figure shows the ASA physical status distribution between both 
the study groups.  
 
 
 
 
Figure 19: ASA-PS between two groups 
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Size of SAD 
 
The following table shows the distribution of study sample based on the 
size of SAD inserted. Maximum number of size 3 SAD were inserted in BM 
(57.1%, n=20). Equal number of size 4 supraglottic device was found in both the 
groups. Chi-square tests were 1.429 which is not statistically significant (p<0.05).  
 GROUP Total Pearson 
Chi-
Square 
p-value 
BM PLM   
SIZE OF 
SAD 
3 20 
(57.1%) 
15 
(42.9%) 
35 1.429a >0.05 
4 15 
(42.9%) 
20 
(57.1) 
35   
Total 35 35 70   
Table 10: Size of SAD 
 
The following figure shows the size of SAD used in both the two groups.    
 
 
Figure 20 : Size of SAD 
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Number of attempts 
The following tables shows the distribution of sample size based on the 
number of attempts required to place the supraglottic airway device. BM group 
had more number of single attempt insertions (n=32, 91.4%) compared to PLM 
group (n=29, 82.9%). Chi-square tests shows a value of 1.148 with p>0.05 which 
is not statistically significant.   
 GROUP Total 
p-
value 
Pearson 
Chi-
Square 
p-
value 
BM PLM   
NO.OF 
ATTEMPTS 
1 32 
(91.4%) 
29 
(82.9%) 
61 1.15 >0.05 
2 3 (8.6%) 6 (17.1%) 9   
Total 35 35 70   
Table 11: Number of attempts 
 
The following figure shows the number of attempts between both the groups. 
                                                                                        
 
 
Figure 21: Number of attempts 
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Ease of insertion grading 
The following table shows the ease of insertion grading between both the 
study groups. Majority of the cases were easy to insert (BM=85.7%; 
PLM=65.7%). Difficulty and slight difficulty was higher among PLM group 
(11.4% and 22.9% respectively). Chi-square test shows a value of 3.864 which is 
statistically significant. 
 
 GROUP Total Pearson 
Chi-
Square 
p-
value 
BM PLM   
EASE OF 
INSERTION 
GRADING 
EASY 30 
(85.7%) 
23 
(65.7%) 
53 3.85 <0.05 
SLIGHT 
DIFFICULTY 
3 
(8.6%) 
8 
(22.9%) 
11   
 DIFFICULT 2 
(5.7%) 
4 
(11.4%) 
6   
Total 35 35 70   
 
Table 12: Ease of insertion grading 
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The following figure shows the distribution of study population based on the 
Ease of insertion grading of SAD.  
 
 
 
 
Figure 22: Ease of insertion grading 
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Number of manipulations 
 
Table 13 shows the number of manipulations required to place the SAD 
between two groups along with chi-square tests. The number of manipulations 
were higher among PLM (n=12) compared to BM (n=5). Number of single and 
double manipulations were higher in PLM compared to BM. Chi-square test 
revealed a score of 3.925 (p>0.05) which is not statistically significant.  
 
 GROUP Total 
p-
value 
Pearson 
Chi-
Square 
p-
value 
BM PLM   
NO. OF 
MANIPULATIONS 
1 3 
(8.6%) 
6 
(17.1%) 
9 3.93 >0.05 
2 2 
(5.7%) 
6 
(17.1%) 
8   
NIL 30 23 53   
Total 35 35 70   
 
Table 13: Number of Manipulations 
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The following figure shows the distribution of study participants based on the 
number of manipulations required to insert SAD. 
 
 
 
Figure 23: Number of manipulations 
 
 
 
Complications and untoward hemodynamic changes 
There were no complications during insertion of SAD in both the groups. 
There were no intraoperative complications including any untoward 
hemodynamic changes in both the groups. 
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Complications during emergence 
The following table shows the complications during emergence between 
both the groups. Blood staining of SAD was more among BM (20%), Nausea was 
found more in PLM (17.1%), vomiting was more among PLM (17.1%) while 
secretions staining SAD was equal in both the groups. Chi-square test for 
different complications during emergency revealed a score of 7.13 (p>0.05) 
which is not statistically significant.  
 
COMPLICATIONS DURING 
EMERGENCY 
GROUP Total Chi-
Square 
p-
value 
BM PLM   
 NO 18 
(51.4%) 
19 
(54.3%) 
37 7.13 >0.05 
BLOOD STAINING OF SAD 7 (20%) 1 (2.9%) 8   
NAUSEA 3 (8.6%) 6 
(17.1%) 
9   
SECRETIONS 
STAININGSAD 
3 (8.6%) 3 (8.6%) 6   
VOMITING 4 
(11.4%) 
6 
(17.1%) 
10   
Total 35 35 70   
 
Table 14: Complications during emergence 
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Laryngopharyngeal morbidity score 
The following table shows the Laryngopharyngeal morbidity score 
distribution among the study population. PLM group has a maximum score of 2 
in 57.1% of the cases while BM group has 51.4% in the same score. BM group 
has more number of Laryngopharyngeal morbidity score of 1 compared to PLM 
group. Chi-square tests shows a value of 7.272 with p<0.05 which is statistically 
significant.  
 
LPM SCORE GROUP Total Chi-
square 
p-value 
BM PLM   
 1 16 
(45.7%) 
8 
(22.9%) 
24 7.27 <0.05 
2 18 
(51.4%) 
20 
(57.1%) 
38   
3 1 
(2.9%) 
7 (20%) 8   
Total 35 35 70   
 
Table 15:  Comparison of Laryngopharyngeal Morbidity Score 
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Insertion time 
 
The mean insertion time is higher for PLM with mean = 36.69 (S.D=8.341) 
against BM with mean = 33.37 (S.D=10.781). The means significantly differ 
between the two groups with p<0.005.  
 
 
 
Figure 24: Mean insertion time in seconds  
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Duration in oropharynx 
The following table shows the duration of supraglottic airway device in 
oropharynx for the two groups. The mean duration in oropharynx is considerably 
higher for PLM (mean=70.34, S.D=27.69) compared to BM (mean=61.23, 
S.D=27.55). The p-value is not statistically significant between both the groups.   
 
Duration in Oropharynx 
 BM PLM 
Mean 70.34 61.23 
S.D 27.69 27.55 
p-value >0.05 
 
Table 16: Mean duration in Oropharynx in minutes  
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The following figure show the mean duration of SAD in oropharynx in the two 
groups.  
 
  
 
 
Figure 25: Mean duration in oropharynx in minutes  
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Airway sealing pressure  
 
The following figures show the distribution of airway sealing pressure in 
the two groups. The mean airway sealing pressure was higher in BM compared 
to PLM at 5 minutes, 30 minutes and at the end of the surgery.  
 
 
 
Figure 26: Airway sealing pressure for BM 
 
 
 
 
 
Figure 27: Airway sealing pressure for PLM 
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Multivariate analysis 
 
The following tables show the multivariate analysis of airway sealing pressure 
between two groups. They vary significantly between groups with p<0.05.  
 Dependent Variable Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
 AIRWAY SEALING PRESSURE AT 
5MINS 
                  
36.013 
1 36.013 6.318 .003 
 AIRWAY SEALING PRESSURE AT 
30MINS 
68.014a 1 68.014 8.217 .006 
AIRWAY SEALING PRESSURE 
END OF SURGERY 
80.357b 1 80.357 9.257 .003 
Table 17: Multivariate analysis of airway sealing pressure 
 
 Dependent Variable GROUP BM GROUP PLM  
 MEAN AIRWAY SEALING PRESSURE AT 
5MINS 
25.914 21.257 
 MEAN AIRWAY SEALING PRESSURE AT 
30MINS 
27.742 25.177 
MEAN AIRWAY SEALING PRESSURE END 
OF SURGERY 
30 26.984 
Table 18: Mean airway sealing pressure   
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CHAPTER 12 
DISCUSSION: 
Supraglottic airway management devices comprise a family of medical 
devices that facilitate oxygenation and ventilation without endotracheal 
intubation. Second-generation SGAs including LMA ProSeal and i-gel were 
introduced in 2000 and 2007, respectively. They provide better airway sealing 
characteristics than classic LMA, have an additional drainage tube for stomach 
decompression to reduce the risk of pulmonary aspiration, and are designed for 
use with spontaneous or positive pressure ventilation (PPV). Baska mask is a 
newer third generation supraglottic airway device according to new Miller’s 
classification of SAD in 2014[19], with additional safety features, requiring 
comparative studies with the existing second generation devices to evaluate its 
safety and efficacy.   
In our study we compared the gold standard second generation supraglottic 
device, Proseal LMA with the newer BASKA mask in patients undergoing 
General anaesthesia with intermittent positive pressure ventilation. This study 
was conducted to compare the airway sealing pressure of the BASKA mask and 
Proseal LMA and to find out the ease of insertion, time taken for insertion of 
SAD, number of manipulations required and perioperative complications 
between BASKA mask and Proseal LMA.  
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  70 patients were studied, 35 in each group. Analyzing the demographic 
profile there were more females (64.29%) in our study with 68.6% females in BM 
group and 60% females in PLM group. Comparing the two groups more females 
were there in PLM group. In a Cohort study conducted by Saito et al[47] on 
difficult ventilation via a supraglottic airway device they demonstrated an 
independent increase in the risk of difficult ventilation via a SAD for male 
patients. This is related to the greater incidence of increased upper airway 
resistance in men compared with women, leading to upper airway narrowing, 
obstruction and obstructive sleep apnea. This is in contrary to our study where 4 
out of 6 difficult supraglottic device insertions was found in females. This we 
conclude may be due to selection of supraglottic airway device based on actual 
weight rather than ideal weight.  
There was no significant difference in the two groups with regards to mean 
age (BM Group=33.09, PLM Group= 37.37). Abramson et al[48] demonstrated 
age-related changes in the airway, in that the upper airway becomes more 
elliptical, less uniform and less compact as confirmed with three-dimensional 
computed tomography. These anatomical changes explain the increased risk of 
difficult mask ventilation with age which is also a plausible explanation for 
difficult ventilation via a SAD. In a retrospective review conducted by Saito et 
al[47] on 14,480 south east Asian population it was concluded that age > 45 years 
is an independent risk factor for difficult ventilation via a supraglottic device. 
 
 
88 
 
This is against the finding in our study, where the mean age for patients with 
difficult SAD placement was 37.17.  
There was no significant difference in the two groups with regards to mean 
BMI (BM Group=22.14, PLM Group= 22.73). In South-East Asians, the body 
mass index is significantly lower than that of the Western population[49].  
 ASA physical status and Modified Mallampatti scores were similar 
between both the groups. In BM group 65.7% of study population belonged to 
ASA-PS I and 34.3% belonged to ASA-PS II. In PLM group 60% of the study 
population belonged to ASA-PSI and 40% ASA-PS II. 48.6% of patients in BM 
group had MMS-I while 51.4% had MMS-II  on airway examination. There were 
no patients with MMS-III in BM group. In PLM group 37.1% of patients had 
MMS-I, 60% had MMS-II and 2.9% had MMS-III grade.  
In our study, 57.1% of patients underwent surgery with size 3 BM inserted, 
whereas 42.9% received size 4 BM. In PLM group 42.9% patients received size 
3 PLM and 57.1% received size 4 PLM. There was no statistical significance in 
terms of size of SAD inserted between both the groups.    
We found that most of our patients in BM group (91.4%, n=32 out of 35) 
had SAD inserted in single attempt while only 82.9% (29 out of 35 patients) had 
successful single attempt SAD insertion in PLM group. More than 1 attempt for 
insertion was seen in 8.6% (n=3 out of 35) of patients in BM group and 17.1% 
(n=6out of 35) of patients in PLM group. However there was no statistical 
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significance between both the groups with respect to the number of attempts 
required for supraglottic device insertion. This is in similarity to a study 
conducted by Al-Rawahi SAS et al[37].  
 Patients in PLM group had higher number of manipulations of SAD  
(34.2% with single manipulation in 6 out of 35 patients and double  manipulations 
in 6 out of 35 patients) whereas in BM group only 14.3% of patients required 
manipulations while inserting SAD (single manipulations in 3 out of 35 and 
double manipulations in 2 out of 35 patients). However there was no statistical 
significance in terms of number of manipulations between both the groups which 
is in accordance with the study conducted by Al-Rawahi SAS et al[37].  
 There were no complications while inserting the SAD in both the groups. 
In our study there were no intraoperative complications in both the groups and no 
untoward hemodynamic changes occurred in either of the groups.   
 The mean insertion time of SAD was significantly higher (p<0.005) for 
PLM group with a mean value of 36.69 secs compared to a mean of 33.37 secs in 
BM group in our study. This is in accordance with the study conducted by Al-
Rawahi SAS et al[37], in which the time taken for BM placement (16.43 ± 
4.54secs)  was significantly shorter as compared to PLM (21.45 ± 6.13 secs). 
 In our study it was found that 85.7% of patients (n=30 out of 35) in BM 
group had easy insertion of SAD while only 65.7% (n=23) patients had easy 
insertion in PLM group. The incidence of slight difficult insertion (22.9%, n=8 
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out of 35) and difficult insertion (11.4%, n=4 out of 35) were higher in PLM 
group compared to BM group where slight difficult insertion was found in 8.6% 
(n=3 out of 35) patients and difficult insertion was found in 5.7% (n=2 out of 35) 
of patients. There is a statistical difference between both the groups in terms of 
ease of insertion grading.   
The primary outcome of mean airway sealing pressure was significantly 
higher with a p-value < 0.05 in BM group compared to PLM group at 5 minutes, 
30 minutes and at the end of the surgery which is similar to the study conducted 
by Zundert Tv, Gatt S[34].  
In our study the mean duration of SAD in the oropharynx was higher for 
PLM group (mean=70.34mins) compared to BM group (mean=61.23mins). 
However the p-value was not statistically significant between both the groups.  
In our study there was an increased rate of blood staining of the Baska 
mask following removal (20% of patients, n=7) while only 2.9% (n=1) of patients 
in PLM group had blood staining of SAD following removal. This was similar to 
a study by Alexiev, V et al[36] where there was increased blood staining of Baska 
mask after removal. Complications like nausea and vomiting were more in PLM 
group. 17.1% of patients in PLM group and 8.6% of patients in BM group had 
nausea following removal of SAD. Vomiting was seen in 17.1% (n=6 out of 35) 
of patients in PLM and 11.4% (n=4out of 35) of patients in BM group. Secretions 
staining of the SAD was equal in both the groups (8.6%, n=3 in each group). 
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51.4%(n=18) of the patients in the BM group and 54.3% (19) of patients in PLM 
group did not have any complications during emergence. There is no statistical 
difference in complication rates between both the groups.  
 The laryngopharyngeal morbidity score which includes sore throat, 
dysphagia and hoarseness was significantly higher among PLM group which 
could be because of the inflated cuff in the oropharynx which can absorb 
anesthetic gases leading to increased mucosal pressure. Soliveres et al[50]. 
compared two second generation supraglottic devices and  found that the use of 
LMA-Proseal produces more sore throat as compared to the I-gel which they 
attributed to the soft seal non inflatable mask of I-gel. Similarly Baska mask with 
a non-inflatable cuff produced less postoperative Laryngopharyngeal morbidity 
in our study.  
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CHAPTER 13 
SUMMARY:   
The following observations were made in our study. 
1. Baska mask provides superior airway sealing (higher OLP) compared to 
Proseal LMA. 
2. The insertion time was significantly lower for Baska mask and Baska mask 
was easy to insert. 
3. Insertion characteristics like number of attempts, number of manipulations 
were similar between both the groups.  
4. Incidences of blood staining of the device after removal was higher in 
Baska mask compared to LMA ProSeal.  
5. The postoperative Laryngopharyngeal morbidity scores were higher in 
PLM group in anesthetized adult patients. 
 
CONCLUSION:  
In our study we conclude that Baska mask can be used as an 
alternative for second generation Proseal LMA because of its safety profile 
in terms of higher sealing pressure, shorter insertion time, greater ease of 
insertion with lesser emergence complications and postoperative 
laryngopharyngeal morbidity compared to Proseal LMA.  
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CHAPTER 15 
ANNEXURES  
    
 ETHICAL COMMITTEE APPROVAL LETTER 
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PROFORMA:  
 
• NAME:                      Age:            sex:              Height:         Weight:       BMI:  
• Occupation:                          Address: 
• Hospital no:     
• Consent form: 
• MPC: 
• ASA-PS: 
• DIAGNOSIS: 
• PROCEDURE:  
• SURGERY DATE: 
• DRUGS USED:  
• BASKA MASK / PROSEAL LMA:  
• Size of SAD: 
• Baseline HR:                        NIBP:                    SpO2:  
• INSERTION:  
• SAD insertion time:          secs 
• Attempts to place SAD correctly:  
• Ease of insertion: Easy/ slight difficulty/ difficult/ impossible.  
• Complication duration insertion: 
• Total manipulations:  
• Airway sealing pressure:              
5mins:         cm of H2O      30mins:                             End of surgery:  
• MAINTENANCE:  
• Duration of SAD in oropharynx:         mins  
• Intraoperative complications: yes/no 
• Intraoperative vitals: HR:                          BP:                      SPO2:  
• Untoward haemodynamic changes if any:  
• EMERGENCE:  
• Complications during emergence: yes/no  
• POSTOPERATIVE PERIOD:  LPM score:  
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MASTER CHART: 
 
SL.NO NAME AGE SEX HEIGHT WEIGHT BMI DATE OF SURGERY IP.NO DIAGNOSIS PROCEDURE MPC ASA-PS GROUP SIZE OF SAD
1 JAYALAKSHMI 30 F 154CM 56KG 16/04/2018 1825937 BILATERAL STAGHORN CALCULUS WITH RIGHT UPPER URETERIC CALCULUSB/L URSL WITH DJ STENTING II II BM 4
2 KALAUTHEEN 55 M 160 60 16/04/2018 1825943 LEFT UPPER URETERIC CALCULUS LEFT URSL WITH DJ STENTING I II BM 4
3 KARTHIKA 22 F 153 50 19/04/2018 1826285 LEFT LOWER URETERIC CALCULUS LEFT URSL AND DJ STENTING I I BM 3
4 SARAVANAN 47 M 158 58 19/04/2018 63371/73 GUTB DJ STENT EXCHANGE I I PLM 4
5 GAJALAKSHMI 39 F 157 48 20/04/2018 3092 FIBROID UTERUS B/L URSL WITH DJ STENTING II II BM 3
6 AMBIKA 42 F 154 45 20/04/2018 1826123 LEFT VUJ CALCULUS LEFT URSL AND DJ STENTING I II BM 3
7 AMUDHA 39 F 158 50 23/04/2018 1827604 RIGHT LOWER URETERIC CALCULUS RIGHT URSL AND DJ STENTING II I PLM 3
8 SHAHUL HAMEED 51 M 154 58 23/04/2018 1826869 RIGHT UPPER URETERIC CALCULUS RIGHT URSL AND DJ STENTING II II BM 4
9 DHAMODHARAN 35 M 155 60 23/04/2018 1827190 LEFT UPPER URETERIC CALCULUS LEFT URSL AND DJ STENTING I II BM 4
10 MOHAN 27 M 166 64 24/04/2018 1827197 RIGHT RENAL CALCULUS RIGHT URSL AND DJ STENTING I I BM 4
11 FATHIMA 52 F 154 56 25/04/2018 1827397 LEFT RETAINED STENT WITH VESICAL CALCULUS VESICOLITHOPAXY WITH DJ STENT REMOVAL II II BM 3
12 KARUNISHA 57 F 150 48 25/06/2018 1826812 LEFT UPPER URETERIC CALCULUS LEFT URSL AND DJ STENTING II I BM 3
13 RAGU KUMAR 44 M 165 65 26/04/2018 1827378 POST HYPOSPADIAS REPAIR URETHROCUTANEOUS FISTULADIAGNOSTIC CYSTOSCOPY II I PLM 4
14 GOPI 26 M 160 60 26/04/2018 1827194 RIGHT VUJ CALCULUS RIGHT URSL AND DJ STENTING I I BM 4
15 SABARISH 23 M 164 62 26/04/2018 1810978 BILATERAL URETERIC CALCULUS B/L URSL WITH DJ STENTING II I PLM 4
16 RAJENDREN 52 M 160 70 27/04/2018 1828220 CYSTITIS DIAGNOSTIC CYSTOSCOPY II II PLM 4
17 NAGARAJAN 59 M 158 60 30/04/2018 1826734 RIGHT LOWER URETERIC CALCULUS RIGHT URSL AND DJ STENTING II II PLM 4
18 PRAVEENA 18 F 150 45 16/04/2018 1822979 LEFT FIROADENOMA EXCISION BIOPSY II I BM 3
19 GOKILA 29 F 154 50 16/04/2018 1824286 LEFT AXILLARY LIPOMA EXCISION BIOPSY I I PLM 3
20 POOVITHA 18 F 152 48 17/04/2018 1825168 RIGHT FIBROADENOMA EXCISION BIOPSY I I BM 3
21 SARAN KUMAR 25 M 160 60 18/04/2018 1832108 LEFT INGUINAL HERNIA OPEN HERNIOPLASTY II II BM 4
22 MURUGAN 54 M 158 65 18/04/2018 1830563 LEFT INGUINAL HERNIA OPEN HERNIOPLASTY II II PLM 4
23  BALAKRISHNAN 18 M 156 40 19/04/2018 1821286 RIGHT AXILLARY LYMPHADENOPATHY EXCISION BIOPSY I I BM 3
24 BABY 23 F 159 45 19/04/2018 1833149 LEFT FIBROADENOMA EXCISION BIOPSY I I BM 3
25 RAJESHWARI 19 F 153 42 20/04/2018 1832109 RIGHT FIBROADENOMA EXCISION BIOPSY II I PLM 3
26 VAJRAVEL 57 M 162 64 20/04/2018 1830591 INCISIONAL HERNIA MESH REPAIR II II PLM 4
27 HEMALATHA 18 F 156 50 02/05/2018 1829780 LEFT FIBROADENOMA EXCISION BIOPSY I I BM 3
28 NAGAJOTHI 33 F 162 65 02/05/2018 1829447 LEFT FIBROADENOMA EXCISION BIOPSY III I PLM 4
29 MALLIGA 47 F 158 56 04/05/2018 1828648 PARAUMBILICAL HERNIA MESH REPAIR II I BM 4
30 MONIKA 18 F 150 42 08/05/2018 1831558 LEFT FIBROADENOMA EXCISION BIOPSY I I PLM 3
31 MARY 18 F 155 48 11/05/2018 1831528 LEFT FIBROADENOMA EXCISION BIOPSY I I PLM 3
32 SUMATHY 43 F 160 62 12/05/2018 1827580 RECURRENT INCISIONAL HERNIA MESH REPAIR II II BM 4
33 NAVEENKUMAR 27 M 165 70 16/05/2018 1826136 BILATERAL GYNAECOMASTIA WEBSTERS PROCEDURE II I BM 4
34 SOUNDARYA 18 F 158 38 18/05/2018 1828371 RIGHT FIBROADENOMA EXCISION BIOPSY I I BM 3
35 KASTHURI 52 F 156 58 18/06/2018 1837352 INCISIONAL HERNIA MESH REPAIR II II PLM 3
36 SATHYARATHI 30 F 152 45 19/06/2018 1838810 HIDRADENITIS SUPPURATIVA WIDE LOCAL EXCISION I I PLM 3
37 AISHAGANI 32 F 154 50 20/06/2018 1832505 POST TOILET MASTECTOMY RAW AREA SSG WITH SECONDARY SUTURING II II PLM 3
38 RAVANA 23 F 154 40 21/06/2018 1837458 POST ILEOSTOMY STATUS ILEOSTOMY TAKE DOWN II II PLM 3
39 INDUMATHI 25 F 157 60 25/06/2018 1837437 INCISIONAL HERNIA MESH REPAIR II I PLM 4
40 MEGATHA 55 F 158 62 28/06/2018 1839692 POST ILEOSTOMY STATUS ILEOSTOMY TAKE DOWN II II PLM 4
41 ELUMALAI 60 M 160 50 01/07/2018 1839539 AXILLARY LYMPHOMA EXCISION BIOPSY II II PLM 3
42 VIJAYA 58 F 154 65 03/07/2018 1842044 EPIGASTRIC HERNIA MESH REPAIR II II PLM 4
43 NANDHA KUMAR 47 M 166 70 04/07/2018 1842161 UMBILICAL HERNIA MESH REPAIR II I BM 4
44 VANATHAIYAN 52 M 156 60 05/07/2018 1837655 RIGHT GYNAECOMASTIA EXCISION BIOPSY II I BM 4
45 VELANKANNI 25 F 150 45 06/07/2018 1842468 LEFT FIBROADENOMA EXCISION BIOPSY II I PLM 3
46 JAYABALAN 59 M 158 63 09/07/2018 1843410 UMBILICAL HERNIA WITH LEFT INGUINAL HERNIA MESH REPAIR/HERNIOPLASTY II II PLM 4
47 NASRIN 35 F 154 50 11/07/2018 1842332 LEFT BREAST FIBROADENOMA EXCISION BIOPSY II I BM 3
48 SRIDHAR 24 M 158 66 11/07/2018 1842331 LEFT GYNAECOMASTIA WEBSTERS PROCEDURE I I PLM 4
49 PARIMALA 28 F 154 48 12/07/2018 1846918 LEFT BREAST FIBROADENOMA EXCISION BIOPSY I I PLM 3
50 JAYA 30 F 153 62 21/07/2018 1845729 PARAUMBILICAL HERNIA ANATOMICAL MESH REPAIR II II PLM 4
51 PARVEEN 18 F 150 45 21/07/2018 1847690 LEFT FIBROADENOMA EXCISION BIOPSY I I PLM 3
52 RAMAKRISHNAN 40 M 160 68 22/07/2018 1847234 EPIGASTRIC HERNIA MESH REPAIR II II PLM 4
53 SANGEETHA 23 F 154 50 23/07/2018 1849072 HIDRADENITIS SUPPURATIVA EXCISION BIOPSY II I PLM 3
54 MALIYA 19 F 148 40 24/07/2018 1844193 RIGHT FIBROADENOMA BREAST EXCISION BIOPSY I I PLM 3
55 AARTHI 18 F 150 45 25/07/2018 1852593 LEFT FIBROADENOMA EXCISION BIOPSY I I BM 3
56 SELVI 47 F 152 56 26/07/2018 1854830 RIGHT FIBROADENOMA EXCISION BIOPSY I I PLM 4
57 KATHIRVEL 45 M 158 64 27/07/2018 1858741 UMBILICAL HERNIA MESH REPAIR I I PLM 4
58 AMUDHA 40 F 154 50 28/07/2018 1855330 LEFT LUMP FIBROCYSTIC DISEASE EXCISION BIOPSY I I BM 3
59 SHANMUGAM 50 M 162 68 13/08/2018 1852182 BILATERAL INGUINAL HERNIA STOPPAS PROCEDURE II II BM 4
60 RAJA 48 M 165 60 14/08/2018 1854588 AXILLARY LIPOMA EXCISION BIOPSY II II PLM 4
61 NAGAMMAL 28 F 162 55 18/08/2018 1852522 BILATERAL FIBROADENOMA EXCISION BIOPSY II I BM 4
62 ANNAKILI 45 F 150 50 18/08/2018 1858158 LEFT FIBROADENOMA EXCISION BIOPSY I I BM 3
63 JAYANDA 38 F 158 60 21/08/2018 1858029 BILATERAL FIBROADENOMA EXCISION BIOPSY I I PLM 4
64 NIVETHA 20 F 152 46 27/08/2018 1860112 RIGHT FIBROADENOMA EXCISION BIOPSY I I BM 3
65 SHAMABANU 18 F 157 40 03/09/2018 1803421 LEFT FIBROADENOMA EXCISION BIOPSY I I BM 3
66 SATHISH 37 M 165 64 05/09/2018 1824748 RIGHT INGUINAL HERNIA RIGHT HERNIOPLASTY I I PLM 4
67 VAITHEGI 18 F 155 55 06/09/2018 1856701 LEFT FIBROADENOMA EXCISION BIOPSY I I BM 3
68 KOWSALYA 34 F 154 58 07/09/2018 1852521 LEFT FIBROADENOMA EXCISION BIOPSY II I BM 4
69 GOMATHY 32 F 158 66 20/09/2018 1857822 RIGHT FIBROADENOMA EXCISION BIOPSY II II BM 3
70 SAHIRA BANU 30 F 150 66 20/09/2018 1860745 SCAR ENDOMETRIOSIS WIDE LOCAL EXCISION II II BM 3
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SL.NO
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
BASELINE HR BASELINE NIBP BASELINE SPO2 AIRWAY SEALING PRESSUREAT 5MINS AIRWAY SEALING PRESSURE AT 30MINSAIRWAY SEALING PRESSURE END OF SURGERY INSERTION TIME NO.OF ATTEMPTS EASE OF INSERTION GRADING
87/MIN 116/80MMHg 98% 25CMH2O 27 28 45secs 1 EASY
78 128/84 98 28 29 32 40 1 EASY
72 110/68 99 28 30 34 42 1 EASY
70 114/76 98 26 28 28 38 1 EASY
99 110/60 98 24 26 28 36 1 EASY
90 126/76 99 27 29 30 35 1 EASY
82 120/78 99 26 27 30 36 1 EASY
76 128/70 97 24 26 28 30 1 EASY
88 130/86 98 28 30 32 30 1 EASY
84 120/88 98 30 30 32 32 1 EASY
80 124/76 98 26 28 30 45 2 DIFFICULT 
85 130/90 98 28 28 30 30 1 EASY
76 110/80 98 30 32 32 34 1 EASY
80 116/80 97 28 30 32 30 1 EASY
68 122/74 98 26 26 30 38 2 DIFFICULT
75 130/84 97 24 25 27 35 1 EASY
64 124/80 97 28 29 30 36 2 DIFFICULT
92 110/70 99% 24 28 30 40 1 EASY
78 100/70 98 18 22 24 60 1 SLIGHT DIFFICULTY
96 120/74 98 20 23 25 45 1 EASY
70 126/80 98 24 25 28 30 1 EASY
68 130/80 98 20 23 28 50 2 EASY
90 110/74 99 18 24 26 30 1 EASY
88 114/76 99 24 25 29 20 1 EASY
80 112/70 99 19 22 26 45 2 DIFFICULT
72 130/90 97 22 23 24 52 1 EASY
100 110/70 98 20 24 28 30 1 EASY
75 128/84 98 18 22 24 50 1 SLIGHT DIFFICULTY
84 120/88 98 28 30 34 28 1 EASY
110 130/80 99 26 26 28 38 1 EASY
94 116/74 99 30 32 34 20 1 EASY
90 118/88 99 25 26 27 24 1 EASY
98 126/90 99 28 30 32 25 1 EASY
88 110/68 99 30 32 33 28 1 EASY
86 114/70 98 27 28 32 38 2 DIFFICULT
84 120/70 98 25 28 30 40 1 EASY
76 100/60 98 48 30 30 32 2 SLIGHT DIFFICULTY
66 104/70 98 20 23 24 26 1 EASY
96 130/84 98 27 28 29 30 1 EASY
90 108/68 99 28 29 30 32 1 EASY
78 130/90 97 24 28 30 20 1 EASY
72 124/80 98 28 28 30 34 1 SLIGHT DIFFICULTY
70 130/80 98 29 30 32 25 1 EASY
76 126/78 99 29 30 34 20 1 EASY
86 118/72 98 22 24 24 38 1 EASY
76 128/68 98 26 28 32 35 1 SLIGHT DIFFICULTY
74 110/72 99 28 28 30 25 1 EASY
80 126/72 99 26 28 30 35 1 EASY
70 106/66 99 25 26 28 30 1 EASY
72 126/86 98 20 21 24 35 1 EASY
70 120/72 99 18 20 22 30 1 EASY
84 130/80 98 20 22 24 38 1 SLIGHT DIFFICULTY
83 128/70 99 18 20 22 30 1 EASY
110 110/68 99 20 22 23 32 1 EASY
104 114/60 99 23 24 25 28 1 SLIGHT DIFFICULTY
100 118/70 98 24 25 28 35 1 EASY
92 120/72 99 25 26 27 34 1 EASY
96 124/70 98 26 27 28 30 1 EASY
80 130/92 99 32 34 35 40 1 SLIGHT DIFFICULTY
72 128/80 98 26 27 29 50 1 EASY
84 112/74 99 22 24 26 30 1 EASY
68 104/70 98 26 28 30 25 1 EASY
73 108/70 99 24 26 30 38 1 SLIGHT DIFFICULTY
94 124/76 99 27 28 32 28 1 EASY
90 108/70 99 26 28 30 25 1 EASY
74 118/76 99 26 28 32 40 1 SLIGHT DIFFICULTY
86 120/68 99 24 26 30 45 2 DIFFICULT
80 122/76 98 28 29 32 22 1 EASY
92 137/94 98 26 28 30 60 2 SLIGHT DIFFICULTY
90 124/80 98 24 27 28 70 1 EASY
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SL.NO
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
NO.OF MANIPULATIONS DURATION IN OROPHARYNX COMPLICATIONS DURING INSERTION INTRAOPERATIVE C MPLICATIONS DURING EMERGENCE  UNTOWARD HEMODYNAMIC CHANGES IF ANY CO PLI ATIONS DURING EMERGENCE LPM SCORE 
NIL 60MINS NO NO NO NAUSEA 2
NIL 35 NO NO NO BLOOD STAINING OF SAD 1
NIL 40 NO NO NO NO 2
NIL 35 NO NO NO NO 1
NIL 35 NO NO NO NO 2
NIL 35 NO NO NO NO 1
NIL 40 NO NO NO NO 1
NIL 50 NO NO NO BLOOD STAINING OF SAD 2
NIL 60 NO NO NO NAUSEA 2
NIL 45 NO NO NO NO 1
2 100 NO NO NO BLOOD STAINING OF SAD 2
NIL 60 NO NO NO NO 1
NIL 45 NO NO NO NO 1
NIL 45 NO NO NO NAUSEA 1
2 115 NO NO NO NAUSEA 2
NIL 35 NO NO NO NAUSEA 1
2 40 NO NO NO NO 2
NIL 60 NO NO NO NO 1
1 90 NO NO NO NAUSEA 3
NIL 45 NO NO NO BLOOD STAINING OF SAD 2
NIL 100 NO NO NO SECRETIONS STAINING  SAD 2
NIL 90 NO NO NO NO 2
NIL 60 NO NO NO NO 1
NIL 40 NO NO NO BLOOD STAINING OF SAD 1
2 50 NO NO NO VOMITING 3
NIL 62 NO NO NO NO 2
NIL 45 NO NO NO NO 2
1 60 NO NO NO VOMITING 3
NIL 110 NO NO NO NO 2
NIL 70 NO NO NO SECRETIONS STAINING OF SAD 2
NIL 50 NO NO NO BLOOD STAINING OF SAD 2
NIL 118 NO NO NO NO 2
NIL 112 NO NO NO BLOOD STAINING OF SAD 2
NIL 93 NO NO NO NO 1
2 110 NO NO NO VOMITING 3
NIL 75 NO NO NO NO 2
1 60 NO NO NO SECRETIONS STAINING OF SAD 1
NIL 120 NO NO NO NO 3
NIL 110 NO NO NO NAUSEA 2
NIL 90 NO NO NO SECRETIONS STAINING OF SAD 2
NIL 50 NO NO NO NAUSEA 2
1 100 NO NO NO NO 2
NIL 75 NO NO NO NO 1
NIL 50 NO NO NO NO 1
NIL 30 NO NO NO NO 1
2 115 NO NO NO NO 3
NIL 40 NO NO NO BLOOD STAINING OF SAD 1
NIL 65 NO NO NO NAUSEA 2
NIL 35 NO NO NO NO 1
NIL 85 NO NO NO NO 2
NIL 40 NO NO NO NO 1
1 80 NO NO NO NO 2
NIL 95 NO NO NO NO 2
NIL 55 NO NO NO NO 2
1 45 NO NO NO NO 1
NIL 40 NO NO NO NO 2
NIL 70 NO NO NO VOMITING 2
NIL 60 NO NO NO VOMITING 2
1 120 NO NO NO NO 2
NIL 55 NO NO NO VOMITING 2
NIL 75 NO NO NO VOMITING 2
NIL 40 NO NO NO NO 1
1 100 NO NO NO VOMITING 2
NIL 30 NO NO NO SECRETIONS STAINING OF SAD 1
NIL 45 NO NO NO NO 1
2 100 NO NO NO NO 3
2 60 NO NO NO NO 2
NIL 50 NO NO NO SECRETIONS STAINING OF SAD 2
1 90 NO NO NO VOMITING 3
NIL 15 NO NO NO VOMITING 2
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ÑV Jl×Rp T¥Ym 
 
BWônf£ ¨ûXVm  :  UVdL UÚkÕ Õû\ (©¬Ü) 
  vPôu­ UÚjÕY Lpí¬ 
RûXl×  : ùTôÕ UVdL UÚk§u úTôÕ TvLô Utßm  
  lúWôºp Gp.Gm.H.®u JlÀhÓ BnÜ 
TeÏ ùTßTY¬u ùTVo : 
TeÏ ùTßTY¬u Gi : 
UÚjÕY Bn®u ®YWeLs G]dÏ ®[dLlThPÕ G]Õ úSôn 
Tt±V NkúRLeLû[ úLhLÜm ARtLô] RÏkR ®[dLeLû[ ùT\Üm 
Yônl× A°dLlThPÕ. CkR úSôûV ÏQlTÓjÕm £¡fûNLs 
................................. ®[dLlThPÕ. CkR Bn®u úSôdLm Utßm ARu 
¨û\, Ïû\Ls Utßm úRûYVô] LôXYûWVûW Aû]jÕm 
®[dLlThPÕ. CkR £¡fûN Øû\Lû[ TVuTÓjR ÑV ¨û]ÜPu 
NmU§d¡ú\u. CkR T¬úNôRû]«u ®û[ÜLû[ Bn®p TVuTÓjR 
Ru²fûNVôL NmU§d¡ú\u. GdLôWQj§]ôÛm GkR LhPj§Ûm GkR 
NhP £dLÞdÏm EhTPôUp CqYôn®p CÚkÕ ®X¡ ùLôs[Xôm 
Gußm A±kÕ ùLôiúPu. 
CkR Bn®u êXm ¡ûPdÏm RLYpLû[Ùm T¬úNôRû]«u 
Ø¥ÜLû[Ùm UÚjÕYo úUtùLôsÞm Bn®p TVuTÓj§ ùLôs[Üm 
AûR ©WÑ¬dL úRûYlThPôp Guû]Ùm G]dÏ SPdÏm 
T¬úNôRû]ûVÙm ×ûLlTPm GÓdLÜm Sôu ØÝU]ÕPu NmU§d¡ú\u. 
TeúLtTY¬u ûLùVôlTm 
Sôs : LhûP®Wp JlTm 
CPm : 
 
TeúLtTY¬u ùTVo Utßm ®XôNm 
BnYô[¬u ùTVo 
CPm : 
 
Nôh£ 1 : Nôh£ 2 : 
ûLùVôlTm : ûLùVôlTm : 
ùTVo : ùTVo : 
ØLY¬ : ØLY¬ :  
 
 RLYp Rôs 
 
CkR BWônf£ûV Tt±V Ød¡VUô] RLYpLû[ ùR¬kÕ ùLôiÓ 
C§p TeúLtL EeLs NmURjûR ùR¬®dÏUôß SôeLs ®ÓjR 
úYiÓúLû[ Htßd ùLôiPûUdÏ Su±, CkR BWônf£, NmUkRUô] 
RLYpLs C§p TeÏ ùTßY§]ôp EeLÞdÏ HtTPdá¥V 
AùN[L¬VeLs Tô§l×Ls Utßm SuûULs Aû]jÕm ClT¥Yj§p 
ùLôÓdLlTh¥Úd¡u\] CûR ¿eL[ôLúY T¥jÕ ùR¬kÕ ùLôs[Xôm 
ApXÕ ¿eLs ®ÚlTlThPôp, SôeLs CûR EeLÞdÏ T¥jÕdLôh¥ 
×¬ÙmT¥ ùNôpYRtÏ RVôWôL CÚd¡ú\ôm. EeLÞdÏ HúRàm 
×¬V®pûX Gu\ôÛm ApXÕ áÓRp RLYpLs HúRàm úRûY 
Gu\ôÛm SôeLs EeLÞdÏ ERY RVôWôL CÚd¡ú\ôm. 
1.  CkR Bn®u úSôdLm Gu]? 
CkR Bn®u úSôdLm AßûY £¡fûN«u úTôÕ TvLô Utßm 
lúWôºp Gp.Gm.H. GÕ £\kRÕ GuTûR LiP±YÕ. 
 
2.  CkR UÚjÕY úNôûR«p Vôo TeúLtL Ø¥Ùm? 
C§p ØuT§Ü ùNnÕ, ØÝ UVdLjÕPu AßûY £¡fûN ùNnV 
YVÕ 18-65 YûW Es[YoLs TeúLtLXôm. 
 
3.  CkR Bn®p Vôo TeúLtLd áPôÕ? 
Lo©¦ ùTiLs, EPp TÚUu Es[YoLs, ×ûWdúLÚm BTjÕ 
Es[YoLs 
 
4.  CkR UÚjÕY úNôRû] SûPØû\ Gu]? 
CkR úNôRû]ûV HtßùLôiP úSôVô°Lû[ úRôWôVUôL 
CÚ©¬ÜL[ôL ©¬jÕ BnÜ úUtùLôs[lTÓm. 
 Ïìl PLM - lúWôºp Gp.Gm.H. ûYjÕ ØÝ UVdLm ùLôÓdLlTÓm. 
 Ïìl BM - TôvLô Gp.Gm.H. ûYjÕ ØÝ UVdLm ùLôÓdLlTÓm. 
 
5.  CkR ùNnØû\«u SuûULs Gu]? 
 CkR AßûY £¡fûN Ø¥kR©u ùRôiûP Y­, ®ÝeÏY§p 
£WUm, ÏWp Uôt\m úTôu\ TdL®û[ÜLs Ïû\YôL CÚdÏm 
GuTûRÙm VôÚdùLpXôm ×úWôºp Utßm TvLô Gp.Gm.H. 
ETúVô¡pLXôm GuTûRÙm LiP±V Ø¥Ùm. 
 
6. CkR ùNVpØû\«u ©u ®û[ÜLs Gu]? 
 CkR úNôRû]«u ùYt± úSôVô°«u EPp ¨ûX ùTôÚjÕs[Õ. 
 
7. CkR UÚjÕY úNôRû]«p úNÚYÕ LhPôVUô? 
 CpûX CkR UÚjÕY úNôRû]«p úNÚYÕ EeLs ®ÚlTm, 
¿eLs GkR úSWj§Ûm CkR UÚjÕY úNôRû]ûV ®hÓf ùNpX 
Ø¥Ùm. 
 
8. Guû]l Tt±V RLYp CWL£VUôL CÚdÏUô? 
 Bm. EeLs ùTVo Utßm R²lThP ®YWeLs CWL£VUôL 
CÚdÏm. 
 
9. CkR BWônf£«u Ø¥ÜLs G]dÏ ùRR¬®dLlTÓUô? 
 ¿eLs ®Úm©]ôp, GeL°Pm ùTtßm ùLôs[Xôm. 
 
